Back to search

Article

Small molecule activation of the tumor suppressor kinase LKB1

2024-12-20

Abstract excerpt

The ability to identify and target oncogenic signals has transformed clinical oncology. Drug development for targeted therapies has historically focused on the inhibition of oncogenic kinases and GTPases. However, many cancer patients do not benefit from targeted approaches because their tumors lack targetable mutations. Therapeutic augmentation of tumor suppressive signaling could be a viable alternative but pose...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
574d9352-6ebd-5b02-8fdc-c69f8b56629c
DOI
10.1101/2024.12.17.628051
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Select a neighboring publication to make it the new centre.